Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-23

FDA Approved: SPIRONOLACTONE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved the original application for spironolactone (generic) from Rising Pharma Holdings, Inc., authorizing the marketing of a generic spironolactone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (generic) (Spironolactone)

Snippet

ORIG AP for SPIRONOLACTONE (SPIRONOLACTONE)